NEW YORK (GenomeWeb) – Cytox said today that it has signed a research collaboration deal with the Mayo Clinic to further develop its polygenic risk scoring approach for the diagnosis and prognosis of Alzheimer's disease and other neurological conditions.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.